Medicines for Europe commits at one year anniversary of HERA

Members of the trade group Medicines for Europe, which represents makers of biosimilar and generics drugs, are major suppliers of medicines for health crises. During the COVID pandemic, up to 90% of medicines needed in intensive care units were off patent medicines and our members have donated over 1,200 truckloads of medicines to help Ukraine.

The European Union Health Emergency Response Authority (HERA), established in February 2021 and fully launched in September last year following experience gathered during the pandemic, with the aim of preventing, detecting and rapidly responding to health emergencies.

For example, in June this year, the HERA ordered 110,000 doses of MVA-BN smallpox/monkeypox vaccine, to be made available to European Union member states, from Danish vaccine developer Bavarian Nordic (OMX: BAVA).